← Leaderboards
Xiang Gao
Scientific Horizons Consulting Llc
$628,405
Attributed
$628,405
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $573.4K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$628,405 · 2
By mechanism
R43$628,405 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Lung”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Michelle Rives · Baylor College Of Medicine$20,650,593
- Judith Doherty$11,781,802
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$9,535,571
- Diana Severynse-Stevens · Research Triangle Institute$9,530,685
Research focus
LungGene ExpressionInsightDosageInvestigationCell SurvivalInflammatoryInhalatorsIn VitroSmall Business Innovation Research GrantDoseCytokineCoculture TechniquesInhalationFutureDrynessDosimetryEfficacy EvaluationAlgorithmsAdrenal Cortex HormonesFormulationAtomizerDepositionApical
Grant awards (3)
A Novel Aerosolization and Inhalation Platform for the Pulmonary Delivery of Anti-inflammatory Agents to Distal Airways for the Enhanced Pain Management in Chronic Obstructive Pulmonary Disease (COPD)$55,000
R43 · FY2025 · HL · contact PI
Pulmonary Delivery of Antibiotics Co-crystalized with Cyclodextrin-based Metal Organic Frameworks to Treat Non-Tuberculous Mycobacterial (NTM) Infections$298,530
R43 · FY2024 · AI · contact PI
A Novel Aerosolization and Inhalation Platform for the Pulmonary Delivery of Anti-inflammatory Agents to Distal Airways for the Enhanced Pain Management in Chronic Obstructive Pulmonary Disease (COPD)$274,875
R43 · FY2024 · HL · contact PI